## Abstract ## Background We investigated the effects of vandetanib, an inhibitor of vascular endothelial growth factor receptor 2 (VEGFR‐2) and epidermal growth factor receptor (EGFR), alone and in combination with paclitaxel in an orthotopic mouse model of human head and neck squamous cell carci
Molecular Targets in Squamous Cell Carcinoma of the Head and Neck
✍ Scribed by Keisuke Shirai; Paul E. O’Brien
- Book ID
- 107531992
- Publisher
- Springer
- Year
- 2007
- Tongue
- English
- Weight
- 197 KB
- Volume
- 8
- Category
- Article
- ISSN
- 1527-2729
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Head and neck cancer is a challenging disease that is expected to account for greater than 500,000 new cases worldwide in 2008. Toxicity has impeded advances in chemotherapy and radiation for head and neck cancer, and the prognosis for patients with recurrent and/or metastatic disease r
## Background: The presence of regional metastasis in patients with head and neck squamous cell carcinoma (hnscc) is a common and adverse event associated with poor prognosis and high mortality. although significant improvements in standard therapies have increased the efficacy of local tumor manag
## Background: Squamous cell carcinoma (scc) of the head and neck region is rare in young patients and even less frequent in children 15 years or younger children. the patients reported in the literature are isolated cases and their management is always difficult because there is no large experienc